MedCloud Minute
The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].
AIDS Healthcare Foundation (AHF) has modernized its contract management processes using CloudMoyo’s generative AI-powered IntelliDoc Analyze (CDA) platform. CloudMoyo is a global AI-first consulting solutions firm. The platform is designed to improve efficiency and accelerate document analysis and data extraction. The solution uses AI to analyze contracts, extract key terms, identify obligations and flag potential issues, helping AHF manage agreements more consistently as it operates across multiple regions and regulatory environments. The platform enables faster review cycles while improving visibility into contractual commitments.
More
Posted by MedCloudInsider Editors on 01/20/20260 comments
Katalyze AI, builder of Agentic AI systems for pharmaceutical manufacturing, has launched Katalyst, an agentic AI platform designed specifically for pharmaceutical manufacturing operations. The AI agent is built to help manufacturing teams accelerate scientific decision-making and operate with grounded insights for production data. The platform is designed to operate within existing manufacturing systems, supporting use cases such as deviation analysis, root-cause identification and continuous process optimization while respecting regulatory constraints. Katalyst connects to existing operational systems to combine statistical analysis, advanced data visualizations with scientifically grounded reasoning towards improved production yields.
More
Posted by MedCloudInsider Editors on 01/20/20260 comments
MediKarma, a leader in Agentic AI for healthcare, has launched what it describes as healthcare’s first Agentic AI Licensing Program, designed to give providers and partners access to pre-validated AI agents focused on disease management. The model allows healthcare organizations to license individual agents tailored to specific conditions, rather than building or training systems from scratch. MediKarma's agents are designed to support care coordination, patient engagement and longitudinal disease monitoring while operating within defined clinical and governance boundaries.
More
Posted by MedCloudInsider Editors on 01/12/20260 comments
Impilo, the creator of a hybrid healthcare delivery operating system, has introduced TaylorAI, a digital health concierge agent built to help patients navigate setting up monitoring devices and assist with troubleshooting. The AI agent is designed to answer common questions, assist with scheduling, guide patients through how to use their monitoring devices and explain to patients exactly what is happening in real-time.
More
Posted by MedCloudInsider Editors on 01/12/20260 comments
Function, a medical and health company on a mission to empower humanity to reach 100 years, has launched the Function Connector, an integration with Claude, the large language model developed by Anthropic. The integration allows members to authorize Claude to access lab results and to provide guided health advice that is based on these results. Function said the goal is to make members understand their health-related matters in a simple way that can guide smarter, healthier choices.
More
Posted by MedCloudInsider Editors on 01/12/20260 comments
Recent research reveals that Biotronik Neuro's remote monitoring with real-time visibility into spinal cord stimulation (SCS) usage can support a more effective, long-term approach to managing implanted neurostimulation devices. Biotronik is a leading medical device company aimed at developing improvements for heart and blood vessel diseases. The research examined how continuous data on stimulation patterns and patient engagement can help clinicians better understand therapy adherence, optimize programming and identify issues earlier than traditional follow-up methods. Researchers claim that the approach addresses a long-standing gap in post-implant care, where limited visibility has made it difficult to assess how devices are actually used outside the clinic.
More
Posted by MedCloudInsider Editors on 01/05/20260 comments
Mira Precision Health, specialists in precision medicine diagnostics, has announced the U.S. launch of ToxNav Advantage, an AI-based clinical decision support platform, at the 2026 ASCO Gastrointestinal Cancers Symposium. The software is designed to help oncologists assess and manage treatment-related toxicity risk by analyzing patient-specific data alongside therapy characteristics. Mira intends for ToxNav Advantage to support more informed treatment planning, particularly for gastrointestinal cancers where adverse effects can limit dose intensity or lead to early discontinuation.
More
Posted by MedCloudInsider Editors on 01/05/20260 comments
The Veterans Health Venture Studio (VHVS), an engine designed to develop the pipeline of innovation, expands its Make-a-thon program, an innovation initiative that pairs VA clinicians, engineers, designers and veterans to rapidly develop solutions to unmet needs in health care delivery and daily living. The Make-a-thon is supported by the VA's Office of Healthcare, The American Legion and Microsoft. At its core, the program is powered by Microsoft with expert innovative training, experts and mentorship. The program focuses on hands-on collaboration, enabling teams to prototype assistive devices, clinical tools, and workflow improvements in short, intensive sprints. VA officials want the approach to help translate frontline insights into practical solutions more quickly than traditional procurement or research pathways.
More
Posted by MedCloudInsider Editors on 01/05/20260 comments
Link Cell Therapies, a biotechnology oncology cell therapy company, has officially launched with the mission of accelerating the development of next-generation CAR-T therapies targeting both liquid and solid tumours. The company plans to apply innovations in cell engineering, tumor microenvironment modulation, and safety switches to overcome longstanding challenges that have limited CAR-T efficacy in solid malignancies. Link says its initial programs will advance through preclinical validation with IND-enabling goals, targeting tumor antigens with broad expression profiles and engineered features designed to improve persistence and reduce off-target toxicity.
More
Posted by MedCloudInsider Editors on 12/15/20250 comments
BioTec, a specialized bio company, has introduced two new sulfur-based products designed for industrial and agricultural markets, expanding its portfolio with materials intended to improve performance in applications such as advanced coatings and soil treatment. The company highlighted its new offerings at recent domestic and international exhibitions, emphasizing its formulation technology and its potential to meet evolving customer specifications. BioTec says the products leverage its sulfur-derivative expertise and production infrastructure to deliver consistent quality and scalable supply.
More
Posted by MedCloudInsider Editors on 12/15/20250 comments
Astrin Biosciences, a cancer intelligence company, has established a scientific advisory board to support the development of its AI-enabled proteomics platform for early cancer detection. The new board includes clinicians and researchers with backgrounds in oncology, biomarker discovery and machine learning, who will advise on study design, validation strategies and clinical translation. The development of the board comes post the launch of Astrin's Certitude Breast, a non-imaging screening test that can detect breast cancer in early stages. Astrin claims expert input is critical as it advances toward larger trials and potential regulatory pathways.
More
Posted by MedCloudInsider Editors on 12/08/20250 comments
Inductive Bio, an AI drug discovery partner, has received an award of up to $21 million to advance AI-driven toxicity models intended to improve drug safety assessment and reduce downstream development risk. The company will work with leading academic and biopharmaceutical partners to generate datasets, validate predictive models and evaluate how AI can better characterize off-target effects early in the R&D cycle. Inductive Bio aims to use the initiative to address persistent gaps in preclinical toxicity screening, where conventional models often fail to capture complex biological interactions that later lead to trial delays or program termination.
More
Posted by MedCloudInsider Editors on 12/08/20250 comments